Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Clinical trial NCT00622479 · TERMINATED

Trial details

NCT number: NCT00622479
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2008-05-01
Primary completion: 2010-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.